TMC Life Sciences (KLSE:TMCLIFE) said its profit attributable to owners plunged to 2.9 million ringgit in the fiscal first quarter ended Sept. 30 from 15.1 million ringgit a year earlier.
Earnings per share fell to 0.0017 ringgit, from 0.0087 ringgit a year ago, according to a Monday bourse disclosure.
Revenue shrank to 82 million ringgit from 92.4 million ringgit a year ago, the healthcare services provider said.
The board did not recommend a dividend for the period.
The company is a unit of Thomson Medical Group (SGX:A50).
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。